title: Con: the routine use of aprotinin during pediatric cardiac surgery is not a benefit.
authors.affiliation: Department of Anesthesiology, University of Washington School of Medicine, Seattle 98105-0371, USA.
authors.forename: G D
authors.initials: GD
authors.lastname: Williams
authors.forename: C
authors.initials: C
authors.lastname: Ramamoorthy
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D007611:Aprotinin / Q000009:adverse effects; D001803:Blood Transfusion; D006348:Cardiac Surgical Procedures; D002648:Child; D002675:Child, Preschool; D003365:Costs and Cost Analysis; D006330:Heart Defects, Congenital / Q000601:surgery; D006490:Hemostatics / Q000009:adverse effects; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D018570:Risk Assessment; D013927:Thrombosis / Q000139:chemically induced; D014148:Tranexamic Acid / Q000627:therapeutic use
chemical_list: D000893:Anti-Inflammatory Agents; D006490:Hemostatics; D014148:Tranexamic Acid; D007611:Aprotinin